Long‐term efficacy and safety of etanercept in children with polyarticular‐course juvenile rheumatoid arthritis: Interim results from an ongoing multicenter, open‐label, extended‐treatment trial

Objective To evaluate the long‐term efficacy and safety of etanercept in children with juvenile rheumatoid arthritis (JRA) participating in an ongoing multicenter, open‐label, extended‐treatment trial. All patients had been participants in an initial randomized efficacy and safety trial of etanercep...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Arthritis and rheumatism 2003-01, Vol.48 (1), p.218-226
Hauptverfasser:	Lovell, Daniel J., Giannini, Edward H., Reiff, Andreas, Jones, Olcay Y., Schneider, Rayfel, Olson, Judyann C., Stein, Leonard D., Gedalia, Abraham, Ilowite, Norman T., Wallace, Carol A., Lange, Mary, Finck, Barbara K., Burge, Daniel J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Antirheumatic Agents - administration & dosage Antirheumatic Agents - adverse effects Arthritis, Juvenile - drug therapy Biological and medical sciences Bones, joints and connective tissue. Antiinflammatory agents Child Child, Preschool Disease Progression Etanercept Female Humans Immunoglobulin G - administration & dosage Immunoglobulin G - adverse effects Male Medical sciences Pharmacology. Drug treatments Receptors, Tumor Necrosis Factor - administration & dosage Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!